• 沒有找到結果。

[PDF] Top 20 Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

Has 10000 "Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B" found on our website. Below are the top 20 most common "Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B".

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

... with chronic hepatitis B, 48 weeks of treatment with adefovir dipivoxil resulted in signif- icant histologic improvement, reduced serum HBV DNA levels, and increased ... See full document

10

Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B

Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B

... Adefovir dipivoxil (Hepsera, Gilead Sciences) is an oral prodrug of adefovir, a phosphonate nucleo- tide analogue of AMP with potent activity against the polymerase activity ... See full document

8

Long-term (3-year) Therapy with Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen Negative Chronic Hepatitis B

Long-term (3-year) Therapy with Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen Negative Chronic Hepatitis B

... t e r m a d e f o v i r t h e r a p y f o r c h r o n i c h e p a t i t i s b file over 144 weeks remained consistent with that seen earlier in the ...studies, treatment ... See full document

9

Sustained Hepatitis B e Antigen Seroconversion in Patients with Chronic Hepatitis B after Adefovir Dipivoxil Treatment: Analysis of Precore and Basal Core Promoter Mutants

Sustained Hepatitis B e Antigen Seroconversion in Patients with Chronic Hepatitis B after Adefovir Dipivoxil Treatment: Analysis of Precore and Basal Core Promoter Mutants

... assessing the durability of lamivudine-in- duced HBeAg seroconversion have suggested that longer treat- ment after seroconversion increased sustained ...months of additional lamivudine therapy ... See full document

7

Using Hepatitis B Surface Antigen Quantification to the Management of Hepatitis B

Using Hepatitis B Surface Antigen Quantification to the Management of Hepatitis B

... Assess HBsAg Positive CHB* Evaluate for treatment Negative Assess anti-HBs Negative.. (No antibodies) (Antibodies Positive present).[r] ... See full document

46

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B

... with hepatitis B e antigen (HBeAg)–positive chronic hepatitis B who had not previously received a nucleoside analogue to receive either ...mg of entecavir or ... See full document

1

Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients

Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients

... during the follow up ...up of these patients. One limitation of this study was its relative small sample ...to treatment-experienced patients in general remains to be ...limitation of ... See full document

28

A pre-S gene chip to detect pre-S deletions in hepatitis B virus large surface antigen as a predictive marker for hepatoma risk in chronic hepatitis B virus carriers

A pre-S gene chip to detect pre-S deletions in hepatitis B virus large surface antigen as a predictive marker for hepatoma risk in chronic hepatitis B virus carriers

... respectively. The detection rates for pre-S deletions in these HBV carriers were 70% (14/20) for DNA sequencing and 65% (13/20) for the Pre-S Gene ...that the Pre- S Gene Chip ... See full document

8

Predictors for early HBeAg loss during lamivudine therapy in HBeAg-positive chronic hepatitis B patients with acute exacerbation.

Predictors for early HBeAg loss during lamivudine therapy in HBeAg-positive chronic hepatitis B patients with acute exacerbation.

... detection of peak serum ALT levels due to late ...policy, the average treatment duration was only ...cohort of patients cannot provide information regarding long-term therapeutic efficacy and ... See full document

19

Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study

Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study

... mg for the primary and key secondary virologic ...address the mixed nature of the study population demonstrated consistent findings across all groups assessed; therefore, our findings ... See full document

10

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B

... Suppression of viral replication is a principal goal of therapy in patients with HBeAg-negative chron- ic hepatitis ...analysis of long-term lamivudine therapy in HBeAg-negative patients ... See full document

10

Chronic hepatitis B reactivation and systemic glucocorticosteroid therapy.

Chronic hepatitis B reactivation and systemic glucocorticosteroid therapy.

... of the patients had chronic HBV infection, but the incidence of severe hepatitis was found to be 53%, which was associated with a mortality rate of ...use of ... See full document

2

Successful use of hepatitis B surface antigen-positive liver grafts - an effective source for donor organs in endemic areas: a single-center experience

Successful use of hepatitis B surface antigen-positive liver grafts - an effective source for donor organs in endemic areas: a single-center experience

... Safety of living donors is top priority in all the LDLT ...even for the healthy donor, risk of HBV flare-up in post hepatectomy period was the prime ...course of ... See full document

17

A Predictive Scoring System for the Seroclearance of HBsAg in HBeAg-seronegative Chronic Hepatitis B Patients with Genotype B or C Infection

A Predictive Scoring System for the Seroclearance of HBsAg in HBeAg-seronegative Chronic Hepatitis B Patients with Genotype B or C Infection

... Seroclearance of hepatitis B surface antigen (HBsAg) is the most ideal endpoint in the treatment of chronic hepatitis ...whether the addition ... See full document

27

Determinants of hepatocellular carcinoma in cirrhotic patients treated with nucleos(t)ide analogues for chronic hepatitis B

Determinants of hepatocellular carcinoma in cirrhotic patients treated with nucleos(t)ide analogues for chronic hepatitis B

... daily. Adefovir was not used in the first line but restricted in the rescue setting, per the regulation of the Taiwan National Health ...Insurance. For those who acquired ... See full document

25

Hepatitis B viral factors and treatment responses in chronic hepatitis B

Hepatitis B viral factors and treatment responses in chronic hepatitis B

... From the conventional IIR notch filters, we see that the IIR notch filters can be designed by a two-stage ...place the zeros on the unit circle with angles equal to notch frequen- cies such ... See full document

9

Hepatitis B virus mutants associated with hepatitis b surface antigen loss: Chicken or egg?

Hepatitis B virus mutants associated with hepatitis b surface antigen loss: Chicken or egg?

... The problems to be considered here are not only characterized by a weighted Hamming distance matrix D (as before) but also a cost vector C of all relevant process plans and [r] ... See full document

6

Hepatitis B virus with primary resistance to adefovir

Hepatitis B virus with primary resistance to adefovir

... h e n e w e n g l a n d j o u r n a l o f m e d i c i n e n engl j med 355;3 ...percent of lung volume) among those with a higher amount of potentially recruitable lung, ... See full document

2

Natural history of chronic hepatitis B REVEALed

Natural history of chronic hepatitis B REVEALed

... history of major diseases, dietary intake, as well as habits of cigarette smoking, alcohol consumption and betel nut ...on the day of collection and stored at -70°C until ...France). ... See full document

11

Chronic Hepatitis B Virus Infection and Dyslipidemia

Chronic Hepatitis B Virus Infection and Dyslipidemia

... using the methods of Paffenbarger et al, 12 and computed as an estimate of energy expended in walking, climbing stairs, playing sports, yard work, and so ...on the question- naire. Amount ... See full document

6

Show all 10000 documents...